Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
. SciLifeLab Lund is comprised of a consortium of nine advanced research infrastructures, with a broad spectrum of focuses that include genomics, proteomics, imaging, structural biology, pharmacological
-
on understanding the role of protein dynamics in this process. Main responsibilities You will work together with structural biologists and computational chemists, primarily carrying out molecular simulations
-
security vetting. If security vetting is conducted, the applicant must pass the vetting process to be eligible for employment. Please do not send offers of recruitment or advertising services. Submit your
-
. If security vetting is conducted, the applicant must pass the vetting process to be eligible for employment. Please do not send offers of recruitment or advertising services. Submit your application through
-
://uu.se/om-uu/jobba-hos-oss/ The position may be subject to security vetting. If security vetting is conducted, the applicant must pass the vetting process to be eligible for employment. Please do not send
-
security vetting. If security vetting is conducted, the applicant must pass the vetting process to be eligible for employment. Please do not send offers of recruitment or advertising services. Submit your
-
part of our values. For information about processing of personal data in the recruitment process. It may be the case that a position at KTH is classified as a security-sensitive role in accordance with
-
. Our group is fascinated by one of biology’s deepest questions: how does development—the process by which genes and environments build organisms—shape the potential for populations to evolve? We study
-
properties in patient-derived material. Work duties The main duties involved in a post-doctoral position is to conduct research. Teaching may also be included, but up to no more than 20% of working hours
-
researcher who wants to contribute with research that can provide breakthroughs in how tomorrow’s therapeutic antibodies should be designed to cure previously difficult-to-treat cancer patients. You are